Type 1 diabetes
Type 1 diabetes is an autoimmune condition where the immune system attacks the insulin-producing cells of the pancreas — it isn't caused by diet or lifestyle, and it requires lifelong insulin replacement. It develops in identifiable stages before symptoms appear, and for the first time, a treatment can delay — not prevent — the onset of symptomatic disease in some people identified early through screening. This isn't yet routine care for most patients, so lifelong insulin therapy remains the standard once diagnosed.
Diagnosis and building your care plan
Recognizing Symptoms or Risk
Classic symptoms, or a known family history of type 1 diabetes or other autoimmune conditions.
Confirming Diagnosis
Blood glucose testing, including HbA1c, alongside your clinical picture.
Antibody Testing Where Unclear
Helps distinguish type 1 from other forms of diabetes when the picture isn't straightforward.
Starting Insulin Therapy
An individualized regimen and hands-on training from diagnosis.
Considering CGM and Automated Insulin Delivery
Now the preferred approach to insulin delivery for type 1 diabetes.
Screening for Related Autoimmune Conditions
Thyroid and, where indicated, celiac screening, alongside ongoing follow-up.
Symptoms
- Increased thirst and frequent urination
- Unintended weight loss
- Fatigue
- Blurred vision
- In some cases, a rapid onset over days to weeks
Causes & risk factors
- An autoimmune process that destroys insulin-producing beta cells
- A family history of type 1 diabetes or other autoimmune conditions
- Most often diagnosed in children, teenagers, or young adults, though it can occur at any age
Type 1 diabetes is on the rise in India — the IDF cites an annual incidence of roughly 3.8 per 100,000, and an estimated 229,400 Indian children (aged 0–19) were living with type 1 diabetes as of 2021, a figure that has more than doubled in recent years, with new cases increasing by an estimated 3–5% annually.
The stages of type 1 diabetes
Type 1 diabetes doesn't begin the day symptoms appear — it develops through identifiable stages, which is part of what makes early detection meaningful for some people.
| Stage | What's happening | Symptoms |
|---|---|---|
| Stage 1 | Two or more diabetes-related autoantibodies present; blood glucose still normal | None |
| Stage 2 | Autoantibodies present, with early changes in blood glucose (dysglycemia) | Usually none — this stage is identified through testing, not symptoms |
| Stage 3 | Clinical onset — insulin production has dropped enough to cause symptoms | Increased thirst, frequent urination, weight loss, fatigue — this is the traditional point of diagnosis |
The autoimmune process
The immune system produces antibodies against the pancreas's insulin-producing cells
Insulin production
As beta cells are lost, the pancreas makes progressively less insulin
Blood glucose
Glucose control changes as the stages progress, eventually leading to symptoms
A new development: delaying onset in at-risk individuals
This is a genuinely new development worth understanding accurately — it's meaningful, but it's easy to overstate if described imprecisely.
Delaying onset is not the same as preventing or curing it
- Teplizumab is a treatment that has been shown to delay — not prevent — the onset of symptomatic (stage 3) type 1 diabetes in people already identified at stage 2 through antibody testing
- It applies only to a specific, screening-identified population — typically people with a known risk, such as a close relative with type 1 diabetes, who test positive for autoantibodies before symptoms appear
- Its availability and regulatory status in India are not confirmed as of this review — this is mentioned here for awareness, not as something offered at this practice or as a recommendation
- For anyone already diagnosed with stage 3 (symptomatic) type 1 diabetes, lifelong insulin therapy remains the standard, established treatment — this development doesn't change that
Automated insulin delivery: now the preferred approach
Insulin delivery technology has shifted meaningfully in recent guidance.
Automated insulin delivery (AID) — combining a CGM sensor, an insulin pump, and an algorithm that adjusts dosing automatically — is now recommended as the preferred insulin delivery approach for type 1 diabetes, rather than one option among several. Earlier requirements around C-peptide levels, antibody status, or a minimum duration of insulin treatment before starting a pump or AID system have also been removed, making this a realistic option earlier in your care. See our insulin therapy and CGM pages for more on the components involved.
Separately, recent guidance has begun supporting GLP-1-based therapy as an adjunct for select patients with type 1 diabetes — this is newer evidence, used selectively and individually rather than as a routine addition, and would be discussed with you specifically if relevant.
How it’s diagnosed
Diagnosis is based on blood glucose testing (including HbA1c) alongside the clinical picture; antibody testing can help distinguish type 1 from other forms of diabetes when the picture is unclear.
How it’s treated
Type 1 diabetes is managed with lifelong insulin therapy, individualized to each patient's routine, alongside blood glucose monitoring and, where appropriate, automated insulin delivery — now the preferred approach — plus regular follow-up and screening for related autoimmune conditions.
When to seek care
- Very high thirst, urination, or unexplained weight loss
- Nausea, vomiting, abdominal pain, or fruity-smelling breath (possible diabetic ketoacidosis) — seek emergency care
- Blood glucose readings persistently outside the range agreed with your care team
- Signs of low blood sugar not responding to treatment, or loss of consciousness — seek emergency care
FAQ
Is type 1 diabetes the same as type 2?
No. Type 1 is an autoimmune condition requiring insulin from diagnosis; type 2 usually involves insulin resistance and can sometimes be managed initially without insulin. See the type 2 diabetes page for details.
Can type 1 diabetes be prevented?
Not prevented, but for some people, it may now be delayed. A treatment (teplizumab) has been shown to delay the onset of symptomatic disease in people already identified at an earlier, presymptomatic stage through antibody testing — this applies to a specific, screening-identified group, isn't yet routine care for most patients, and its availability in India isn't confirmed. Type 1 diabetes itself is not caused by diet or lifestyle.
What are the three stages of type 1 diabetes?
Stage 1: autoantibodies present, normal blood glucose, no symptoms. Stage 2: autoantibodies present with early glucose changes, still no symptoms. Stage 3: clinical onset with symptoms — traditionally the point of diagnosis.
What is teplizumab?
A treatment shown to delay the onset of symptomatic (stage 3) type 1 diabetes in people already identified at stage 2 through antibody testing. It delays, rather than prevents or cures, the condition, and applies only to that specific, screening-identified group.
Is teplizumab available in India?
Its availability and regulatory status in India are not confirmed as of this review. This is mentioned for awareness, not as something offered at this practice.
What is automated insulin delivery?
A system combining a continuous glucose monitor, an insulin pump, and an algorithm that automatically adjusts insulin dosing — now recommended as the preferred insulin delivery approach for type 1 diabetes.
Do I need a CGM with type 1 diabetes?
CGM is a core part of modern type 1 diabetes management and a component of automated insulin delivery systems — suitability and specifics are discussed individually. See our CGM page for more detail.
Do I need to be screened for thyroid or celiac disease?
Thyroid function is checked soon after diagnosis and periodically afterward for everyone with type 1 diabetes. Celiac screening is done specifically when there are suggestive symptoms, signs, or lab findings.
Why can type 1 diabetes come on so quickly?
By the time symptoms appear (stage 3), a significant portion of insulin-producing cells have usually already been lost — the preceding autoimmune process (stages 1 and 2) can happen silently over months to years before symptoms become noticeable, sometimes over just days to weeks once they do.
Can adults develop type 1 diabetes?
Yes — while it's most often diagnosed in children, teenagers, and young adults, type 1 diabetes can develop at any age. A slower-onset autoimmune form in adults is sometimes classified separately as LADA — see our autoimmune diabetes (LADA) page.
What causes the autoimmune attack in type 1 diabetes?
The exact trigger isn't fully understood, but it involves the immune system mistakenly attacking the insulin-producing beta cells of the pancreas, in people with a genetic predisposition.
Is type 1 diabetes hereditary?
A family history of type 1 diabetes or other autoimmune conditions raises risk, but most people diagnosed don't have an affected close relative — genetics is a contributing factor, not the sole cause.
How is type 1 diabetes diagnosed?
With blood glucose testing (including HbA1c) alongside your clinical picture; antibody testing can help confirm type 1 diabetes specifically when the picture is unclear.
How common is type 1 diabetes in India?
It's increasing — an estimated 229,400 Indian children were living with type 1 diabetes as of 2021, with new cases rising an estimated 3–5% annually.
Can GLP-1 medicines help with type 1 diabetes?
Recent guidance has begun supporting GLP-1-based therapy as an adjunct for select patients with type 1 diabetes, based on newer evidence — this is individualized and selective, not a routine addition, and would be discussed with you specifically if relevant.
What happens if type 1 diabetes goes untreated?
Without insulin, glucose builds up dangerously and the body can develop diabetic ketoacidosis (DKA), a medical emergency — this is why insulin therapy begins immediately at diagnosis and isn't optional or delayed.
Medical disclaimer: Content on this page is for general education and is not a substitute for individualized medical advice, diagnosis, or treatment. Outcomes vary between patients. Boston Diabetes Center is outpatient / day-care specialty centre with an on-site diagnostic lab and pharmacy — no inpatient beds; imaging and inpatient care are coordinated through partner facilities.